eTable 1. Post-9/11 multiple myeloma cases among WTC-exposed FDNY white male firefighters eTable 2. Myeloma precursor disease screening study: characteristics of MGUS and light-chain-MGUS in WTC-exposed FDNY white male firefighters 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. ...
Immunomodulatory drugs (IMiDs) have become an integral part of therapy for both newly diagnosed and relapsed/refractory multiple myeloma (RRMM). IMiDs bind
Multiple myeloma. N. Engl. J. Med. 364, 1046–1060 (2011). Article CAS PubMed Google Scholar National Cancer Institute. Cancer Stat Facts: Myeloma. https://seer.cancer.gov/statfacts/html/mulmy.html (2021). Cowan, A. J. et al. Global burden of multiple myeloma: a systematic ...
Ailawadhi S, Jacobus S, Sexton R, et al. Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.Blood Cancer J.2018; 8(7):67. doi:10.1038/s41408-018-0102-7. Unger JM, Hershman DL, Osarogiagbon RU, et a...
4 National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Myeloma. Available from: https://seer.cancer.gov/statfacts/html/mulmy.html [Last accessed: April 2024]. 5 Mikhael, J, Ismaila N, Cheung M, et al. Treatment of multiple myeloma...
Multiple myeloma, a rare cancer of the plasma cells in the bone marrow, is diagnosed at an advanced stage in 95% of patients. Survival rates increased only slightly from 1975 to the late 1990s. The introduction of immunomodulatory drugs, beginning in 1999, was associated with an upward turn ...
Cancer stat facts: myeloma. Available from: http://seer.cancer.gov/statfacts/htlm/mulmy.htlm. 2. Anderson KC. Progress and paradigms in multiple myeloma. Clin Cancer Res. 2016;22:5419–5427. 3. Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the...
Activation of STAT3 and STAT5 signaling in epithelial ovarian cancer progression: mechanism and therapeutic opportunity. Cancers. 2019;12:24. Article PubMed Central Google Scholar Lauta VM. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. ...
Multiple myeloma (MM) is a rare tumor characterized by the uncontrolled proliferation of mature monoclonal plasma cells within the bone marrow (BM). It is the second most common blood cancer in Europe and in the United States [1], with an estimate of about 35,730 newly diagnosed MM cases ...
https://seer.cancer.gov/statfacts/html/mulmy.html [4]About Multiple Myeloma. American Cancer Society. https://www.cancer.org/cancer/multiple-myeloma/about/what-is-multiple-myeloma.html [5]Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment. National Cancer Institute. ...